 | • レポートコード：MRC2-11QY02544 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は抗糖尿病薬のグローバル市場について調査・分析したレポートです。種類別（α-グルコシダーゼ阻害剤、ビグアニド、スルホニル尿素、Glp-1アゴニスト、メグリチニド、Dpp-4阻害剤、Sglt–2、チアゾロジネジオン）市場規模、用途別（I型糖尿病、II型糖尿病）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗糖尿病薬の競争状況、市場シェア ・世界の抗糖尿病薬市場：種類別市場規模 2015年-2020年（α-グルコシダーゼ阻害剤、ビグアニド、スルホニル尿素、Glp-1アゴニスト、メグリチニド、Dpp-4阻害剤、Sglt–2、チアゾロジネジオン） ・世界の抗糖尿病薬市場：種類別市場規模予測 2021年-2026年（α-グルコシダーゼ阻害剤、ビグアニド、スルホニル尿素、Glp-1アゴニスト、メグリチニド、Dpp-4阻害剤、Sglt–2、チアゾロジネジオン） ・世界の抗糖尿病薬市場：用途別市場規模 2015年-2020年（I型糖尿病、II型糖尿病） ・世界の抗糖尿病薬市場：用途別市場規模予測 2021年-2026年（I型糖尿病、II型糖尿病） ・北米の抗糖尿病薬市場分析：米国、カナダ ・ヨーロッパの抗糖尿病薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの抗糖尿病薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の抗糖尿病薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの抗糖尿病薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sanofi-Aventis、Eli Lilly、Oramed、Takeda、Boehringer Ingelheim、Novo Nordisk、Halozyme Therapeutics、Bristol-Myers Squibb、Pfizer、Tonghua Dongbao、Biocon、Wockhardt ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Diabetes mellitus is a kind of chronic comprehensive disease mainly caused by glucose metabolism disorder due to absolute or relative deficiency of insulin or decreased insulin sensitivity of target cells. The occurrence of type 2 diabetes mellitus is a combination of peripheral insulin resistance and β cell dysfunction. the result of. When diabetes patients undergo diet and exercise therapy and diabetes care education, blood glucose control can still not reach the treatment goals, the need for drug treatment-Antidiabetic Drug
The global anti-diabetic drug market is expected to witness significant growth during the forecast period. This growth is attributed due to increasing prevalence of diabetes and rising demand for oral anti-diabetic drugs. In addition, sedentary lifestyle, increasing the percentage of obesity, high-stress levels are considered as a major driving factor for the growth of oral anti-diabetic drugs market. Furthermore, technological advancement and medical reimbursements can also help in fuelling the growth of oral antidiabetic drug market. However, the high cost of drugs is considered as a major restraint for the market. Nonetheless ongoing research and huge market potential can bring growth opportunities for anti-diabetic market within the forecast period.
Market Analysis and Insights: Global Antidiabetic Drug Market
The global Antidiabetic Drug market size is projected to reach US$ 49610 million by 2026, from US$ 44610 million in 2020, at a CAGR of 10.0%% during 2021-2026.
Global Antidiabetic Drug Scope and Market Size
Antidiabetic Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antidiabetic Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Antidiabetic Drug market is segmented into
Alpha-Glucosidase Inhibitors
Biguanides, Sulphonylureas
Glp-1 Agonist
Meglitinides
Dpp-4 Inhibitors
Sglt–2
Thiazolodinediones
Segment by Application, the Antidiabetic Drug market is segmented into
Type I Diabetes
Type II Diabetes
Regional and Country-level Analysis
The Antidiabetic Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Antidiabetic Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antidiabetic Drug Market Share Analysis
Antidiabetic Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antidiabetic Drug business, the date to enter into the Antidiabetic Drug market, Antidiabetic Drug product introduction, recent developments, etc.
The major vendors covered:
Sanofi-Aventis
Eli Lilly
Oramed
Takeda
Boehringer Ingelheim
Novo Nordisk
Halozyme Therapeutics
Bristol-Myers Squibb
Pfizer
Tonghua Dongbao
Biocon
Wockhardt
1 Study Coverage
1.1 Antidiabetic Drug Product Introduction
1.2 Market Segments
1.3 Key Antidiabetic Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antidiabetic Drug Market Size Growth Rate by Type
1.4.2 Alpha-Glucosidase Inhibitors
1.4.3 Biguanides, Sulphonylureas
1.4.4 Glp-1 Agonist
1.4.5 Meglitinides
1.4.6 Dpp-4 Inhibitors
1.4.7 Sglt–2
1.4.8 Thiazolodinediones
1.5 Market by Application
1.5.1 Global Antidiabetic Drug Market Size Growth Rate by Application
1.5.2 Type I Diabetes
1.5.3 Type II Diabetes
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antidiabetic Drug Market Size, Estimates and Forecasts
2.1.1 Global Antidiabetic Drug Revenue 2015-2026
2.1.2 Global Antidiabetic Drug Sales 2015-2026
2.2 Global Antidiabetic Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Antidiabetic Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Antidiabetic Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Antidiabetic Drug Competitor Landscape by Players
3.1 Antidiabetic Drug Sales by Manufacturers
3.1.1 Antidiabetic Drug Sales by Manufacturers (2015-2020)
3.1.2 Antidiabetic Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Antidiabetic Drug Revenue by Manufacturers
3.2.1 Antidiabetic Drug Revenue by Manufacturers (2015-2020)
3.2.2 Antidiabetic Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antidiabetic Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antidiabetic Drug Revenue in 2019
3.2.5 Global Antidiabetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Antidiabetic Drug Price by Manufacturers
3.4 Antidiabetic Drug Manufacturing Base Distribution, Product Types
3.4.1 Antidiabetic Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antidiabetic Drug Product Type
3.4.3 Date of International Manufacturers Enter into Antidiabetic Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Antidiabetic Drug Market Size by Type (2015-2020)
4.1.1 Global Antidiabetic Drug Sales by Type (2015-2020)
4.1.2 Global Antidiabetic Drug Revenue by Type (2015-2020)
4.1.3 Antidiabetic Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antidiabetic Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Antidiabetic Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Antidiabetic Drug Revenue Forecast by Type (2021-2026)
4.2.3 Antidiabetic Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antidiabetic Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Antidiabetic Drug Market Size by Application (2015-2020)
5.1.1 Global Antidiabetic Drug Sales by Application (2015-2020)
5.1.2 Global Antidiabetic Drug Revenue by Application (2015-2020)
5.1.3 Antidiabetic Drug Price by Application (2015-2020)
5.2 Antidiabetic Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Antidiabetic Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Antidiabetic Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Antidiabetic Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Antidiabetic Drug by Country
6.1.1 North America Antidiabetic Drug Sales by Country
6.1.2 North America Antidiabetic Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Antidiabetic Drug Market Facts & Figures by Type
6.3 North America Antidiabetic Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Antidiabetic Drug by Country
7.1.1 Europe Antidiabetic Drug Sales by Country
7.1.2 Europe Antidiabetic Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antidiabetic Drug Market Facts & Figures by Type
7.3 Europe Antidiabetic Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Antidiabetic Drug by Region
8.1.1 Asia Pacific Antidiabetic Drug Sales by Region
8.1.2 Asia Pacific Antidiabetic Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Antidiabetic Drug Market Facts & Figures by Type
8.3 Asia Pacific Antidiabetic Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Antidiabetic Drug by Country
9.1.1 Latin America Antidiabetic Drug Sales by Country
9.1.2 Latin America Antidiabetic Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Antidiabetic Drug Market Facts & Figures by Type
9.3 Central & South America Antidiabetic Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Antidiabetic Drug by Country
10.1.1 Middle East and Africa Antidiabetic Drug Sales by Country
10.1.2 Middle East and Africa Antidiabetic Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Antidiabetic Drug Market Facts & Figures by Type
10.3 Middle East and Africa Antidiabetic Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Sanofi-Aventis
11.1.1 Sanofi-Aventis Corporation Information
11.1.2 Sanofi-Aventis Description and Business Overview
11.1.3 Sanofi-Aventis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi-Aventis Antidiabetic Drug Products Offered
11.1.5 Sanofi-Aventis Related Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Corporation Information
11.2.2 Eli Lilly Description and Business Overview
11.2.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Eli Lilly Antidiabetic Drug Products Offered
11.2.5 Eli Lilly Related Developments
11.3 Oramed
11.3.1 Oramed Corporation Information
11.3.2 Oramed Description and Business Overview
11.3.3 Oramed Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Oramed Antidiabetic Drug Products Offered
11.3.5 Oramed Related Developments
11.4 Takeda
11.4.1 Takeda Corporation Information
11.4.2 Takeda Description and Business Overview
11.4.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Takeda Antidiabetic Drug Products Offered
11.4.5 Takeda Related Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Corporation Information
11.5.2 Boehringer Ingelheim Description and Business Overview
11.5.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Boehringer Ingelheim Antidiabetic Drug Products Offered
11.5.5 Boehringer Ingelheim Related Developments
11.6 Novo Nordisk
11.6.1 Novo Nordisk Corporation Information
11.6.2 Novo Nordisk Description and Business Overview
11.6.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Novo Nordisk Antidiabetic Drug Products Offered
11.6.5 Novo Nordisk Related Developments
11.7 Halozyme Therapeutics
11.7.1 Halozyme Therapeutics Corporation Information
11.7.2 Halozyme Therapeutics Description and Business Overview
11.7.3 Halozyme Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Halozyme Therapeutics Antidiabetic Drug Products Offered
11.7.5 Halozyme Therapeutics Related Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Corporation Information
11.8.2 Bristol-Myers Squibb Description and Business Overview
11.8.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Bristol-Myers Squibb Antidiabetic Drug Products Offered
11.8.5 Bristol-Myers Squibb Related Developments
11.9 Pfizer
11.9.1 Pfizer Corporation Information
11.9.2 Pfizer Description and Business Overview
11.9.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Pfizer Antidiabetic Drug Products Offered
11.9.5 Pfizer Related Developments
11.10 Tonghua Dongbao
11.10.1 Tonghua Dongbao Corporation Information
11.10.2 Tonghua Dongbao Description and Business Overview
11.10.3 Tonghua Dongbao Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Tonghua Dongbao Antidiabetic Drug Products Offered
11.10.5 Tonghua Dongbao Related Developments
11.1 Sanofi-Aventis
11.1.1 Sanofi-Aventis Corporation Information
11.1.2 Sanofi-Aventis Description and Business Overview
11.1.3 Sanofi-Aventis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi-Aventis Antidiabetic Drug Products Offered
11.1.5 Sanofi-Aventis Related Developments
11.12 Wockhardt
11.12.1 Wockhardt Corporation Information
11.12.2 Wockhardt Description and Business Overview
11.12.3 Wockhardt Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Wockhardt Products Offered
11.12.5 Wockhardt Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Antidiabetic Drug Market Estimates and Projections by Region
12.1.1 Global Antidiabetic Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Antidiabetic Drug Revenue Forecast by Regions 2021-2026
12.2 North America Antidiabetic Drug Market Size Forecast (2021-2026)
12.2.1 North America: Antidiabetic Drug Sales Forecast (2021-2026)
12.2.2 North America: Antidiabetic Drug Revenue Forecast (2021-2026)
12.2.3 North America: Antidiabetic Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Antidiabetic Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Antidiabetic Drug Sales Forecast (2021-2026)
12.3.2 Europe: Antidiabetic Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Antidiabetic Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Antidiabetic Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Antidiabetic Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Antidiabetic Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Antidiabetic Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Antidiabetic Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Antidiabetic Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Antidiabetic Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Antidiabetic Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Antidiabetic Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Antidiabetic Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Antidiabetic Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Antidiabetic Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Antidiabetic Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antidiabetic Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Antidiabetic Drug Market Segments
Table 2. Ranking of Global Top Antidiabetic Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antidiabetic Drug Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Alpha-Glucosidase Inhibitors
Table 5. Major Manufacturers of Biguanides, Sulphonylureas
Table 6. Major Manufacturers of Glp-1 Agonist
Table 7. Major Manufacturers of Meglitinides
Table 8. Major Manufacturers of Dpp-4 Inhibitors
Table 9. Major Manufacturers of Sglt–2
Table 10. Major Manufacturers of Thiazolodinediones
Table 11. Global Antidiabetic Drug Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Antidiabetic Drug Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Antidiabetic Drug Sales by Regions 2015-2020 (K MT)
Table 14. Global Antidiabetic Drug Sales Market Share by Regions (2015-2020)
Table 15. Global Antidiabetic Drug Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Antidiabetic Drug Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Antidiabetic Drug Sales Share by Manufacturers (2015-2020)
Table 18. Global Antidiabetic Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Antidiabetic Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antidiabetic Drug as of 2019)
Table 20. Antidiabetic Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Antidiabetic Drug Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Antidiabetic Drug Price (2015-2020) (USD/MT)
Table 23. Antidiabetic Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Antidiabetic Drug Product Type
Table 25. Date of International Manufacturers Enter into Antidiabetic Drug Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Antidiabetic Drug Sales by Type (2015-2020) (K MT)
Table 28. Global Antidiabetic Drug Sales Share by Type (2015-2020)
Table 29. Global Antidiabetic Drug Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Antidiabetic Drug Revenue Share by Type (2015-2020)
Table 31. Antidiabetic Drug Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Antidiabetic Drug Sales by Application (2015-2020) (K MT)
Table 33. Global Antidiabetic Drug Sales Share by Application (2015-2020)
Table 34. North America Antidiabetic Drug Sales by Country (2015-2020) (K MT)
Table 35. North America Antidiabetic Drug Sales Market Share by Country (2015-2020)
Table 36. North America Antidiabetic Drug Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Antidiabetic Drug Revenue Market Share by Country (2015-2020)
Table 38. North America Antidiabetic Drug Sales by Type (2015-2020) (K MT)
Table 39. North America Antidiabetic Drug Sales Market Share by Type (2015-2020)
Table 40. North America Antidiabetic Drug Sales by Application (2015-2020) (K MT)
Table 41. North America Antidiabetic Drug Sales Market Share by Application (2015-2020)
Table 42. Europe Antidiabetic Drug Sales by Country (2015-2020) (K MT)
Table 43. Europe Antidiabetic Drug Sales Market Share by Country (2015-2020)
Table 44. Europe Antidiabetic Drug Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Antidiabetic Drug Revenue Market Share by Country (2015-2020)
Table 46. Europe Antidiabetic Drug Sales by Type (2015-2020) (K MT)
Table 47. Europe Antidiabetic Drug Sales Market Share by Type (2015-2020)
Table 48. Europe Antidiabetic Drug Sales by Application (2015-2020) (K MT)
Table 49. Europe Antidiabetic Drug Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Antidiabetic Drug Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Antidiabetic Drug Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Antidiabetic Drug Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Antidiabetic Drug Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Antidiabetic Drug Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Antidiabetic Drug Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Antidiabetic Drug Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Antidiabetic Drug Sales Market Share by Application (2015-2020)
Table 58. Latin America Antidiabetic Drug Sales by Country (2015-2020) (K MT)
Table 59. Latin America Antidiabetic Drug Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Antidiabetic Drug Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Antidiabetic Drug Revenue Market Share by Country (2015-2020)
Table 62. Latin America Antidiabetic Drug Sales by Type (2015-2020) (K MT)
Table 63. Latin America Antidiabetic Drug Sales Market Share by Type (2015-2020)
Table 64. Latin America Antidiabetic Drug Sales by Application (2015-2020) (K MT)
Table 65. Latin America Antidiabetic Drug Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Antidiabetic Drug Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Antidiabetic Drug Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Antidiabetic Drug Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Antidiabetic Drug Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Antidiabetic Drug Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Antidiabetic Drug Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Antidiabetic Drug Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Antidiabetic Drug Sales Market Share by Application (2015-2020)
Table 74. Sanofi-Aventis Corporation Information
Table 75. Sanofi-Aventis Description and Major Businesses
Table 76. Sanofi-Aventis Antidiabetic Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Sanofi-Aventis Product
Table 78. Sanofi-Aventis Recent Development
Table 79. Eli Lilly Corporation Information
Table 80. Eli Lilly Description and Major Businesses
Table 81. Eli Lilly Antidiabetic Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Eli Lilly Product
Table 83. Eli Lilly Recent Development
Table 84. Oramed Corporation Information
Table 85. Oramed Description and Major Businesses
Table 86. Oramed Antidiabetic Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Oramed Product
Table 88. Oramed Recent Development
Table 89. Takeda Corporation Information
Table 90. Takeda Description and Major Businesses
Table 91. Takeda Antidiabetic Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Takeda Product
Table 93. Takeda Recent Development
Table 94. Boehringer Ingelheim Corporation Information
Table 95. Boehringer Ingelheim Description and Major Businesses
Table 96. Boehringer Ingelheim Antidiabetic Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Boehringer Ingelheim Product
Table 98. Boehringer Ingelheim Recent Development
Table 99. Novo Nordisk Corporation Information
Table 100. Novo Nordisk Description and Major Businesses
Table 101. Novo Nordisk Antidiabetic Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Novo Nordisk Product
Table 103. Novo Nordisk Recent Development
Table 104. Halozyme Therapeutics Corporation Information
Table 105. Halozyme Therapeutics Description and Major Businesses
Table 106. Halozyme Therapeutics Antidiabetic Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Halozyme Therapeutics Product
Table 108. Halozyme Therapeutics Recent Development
Table 109. Bristol-Myers Squibb Corporation Information
Table 110. Bristol-Myers Squibb Description and Major Businesses
Table 111. Bristol-Myers Squibb Antidiabetic Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Bristol-Myers Squibb Product
Table 113. Bristol-Myers Squibb Recent Development
Table 114. Pfizer Corporation Information
Table 115. Pfizer Description and Major Businesses
Table 116. Pfizer Antidiabetic Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Pfizer Product
Table 118. Pfizer Recent Development
Table 119. Tonghua Dongbao Corporation Information
Table 120. Tonghua Dongbao Description and Major Businesses
Table 121. Tonghua Dongbao Antidiabetic Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Tonghua Dongbao Product
Table 123. Tonghua Dongbao Recent Development
Table 124. Biocon Corporation Information
Table 125. Biocon Description and Major Businesses
Table 126. Biocon Antidiabetic Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. Biocon Product
Table 128. Biocon Recent Development
Table 129. Wockhardt Corporation Information
Table 130. Wockhardt Description and Major Businesses
Table 131. Wockhardt Antidiabetic Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. Wockhardt Product
Table 133. Wockhardt Recent Development
Table 134. Global Antidiabetic Drug Sales Forecast by Regions (2021-2026) (K MT)
Table 135. Global Antidiabetic Drug Sales Market Share Forecast by Regions (2021-2026)
Table 136. Global Antidiabetic Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 137. Global Antidiabetic Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 138. North America: Antidiabetic Drug Sales Forecast by Country (2021-2026) (K MT)
Table 139. North America: Antidiabetic Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Europe: Antidiabetic Drug Sales Forecast by Country (2021-2026) (K MT)
Table 141. Europe: Antidiabetic Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Asia Pacific: Antidiabetic Drug Sales Forecast by Region (2021-2026) (K MT)
Table 143. Asia Pacific: Antidiabetic Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 144. Latin America: Antidiabetic Drug Sales Forecast by Country (2021-2026) (K MT)
Table 145. Latin America: Antidiabetic Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Middle East and Africa: Antidiabetic Drug Sales Forecast by Country (2021-2026) (K MT)
Table 147. Middle East and Africa: Antidiabetic Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 149. Key Challenges
Table 150. Market Risks
Table 151. Main Points Interviewed from Key Antidiabetic Drug Players
Table 152. Antidiabetic Drug Customers List
Table 153. Antidiabetic Drug Distributors List
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Antidiabetic Drug Product Picture
Figure 2. Global Antidiabetic Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Alpha-Glucosidase Inhibitors Product Picture
Figure 4. Biguanides, Sulphonylureas Product Picture
Figure 5. Glp-1 Agonist Product Picture
Figure 6. Meglitinides Product Picture
Figure 7. Dpp-4 Inhibitors Product Picture
Figure 8. Sglt–2 Product Picture
Figure 9. Thiazolodinediones Product Picture
Figure 10. Global Antidiabetic Drug Sales Market Share by Application in 2020 & 2026
Figure 11. Type I Diabetes
Figure 12. Type II Diabetes
Figure 13. Antidiabetic Drug Report Years Considered
Figure 14. Global Antidiabetic Drug Market Size 2015-2026 (US$ Million)
Figure 15. Global Antidiabetic Drug Sales 2015-2026 (K MT)
Figure 16. Global Antidiabetic Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Antidiabetic Drug Sales Market Share by Region (2015-2020)
Figure 18. Global Antidiabetic Drug Sales Market Share by Region in 2019
Figure 19. Global Antidiabetic Drug Revenue Market Share by Region (2015-2020)
Figure 20. Global Antidiabetic Drug Revenue Market Share by Region in 2019
Figure 21. Global Antidiabetic Drug Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Antidiabetic Drug Revenue in 2019
Figure 23. Antidiabetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Antidiabetic Drug Sales Market Share by Type (2015-2020)
Figure 25. Global Antidiabetic Drug Sales Market Share by Type in 2019
Figure 26. Global Antidiabetic Drug Revenue Market Share by Type (2015-2020)
Figure 27. Global Antidiabetic Drug Revenue Market Share by Type in 2019
Figure 28. Global Antidiabetic Drug Market Share by Price Range (2015-2020)
Figure 29. Global Antidiabetic Drug Sales Market Share by Application (2015-2020)
Figure 30. Global Antidiabetic Drug Sales Market Share by Application in 2019
Figure 31. Global Antidiabetic Drug Revenue Market Share by Application (2015-2020)
Figure 32. Global Antidiabetic Drug Revenue Market Share by Application in 2019
Figure 33. North America Antidiabetic Drug Sales Growth Rate 2015-2020 (K MT)
Figure 34. North America Antidiabetic Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Antidiabetic Drug Sales Market Share by Country in 2019
Figure 36. North America Antidiabetic Drug Revenue Market Share by Country in 2019
Figure 37. U.S. Antidiabetic Drug Sales Growth Rate (2015-2020) (K MT)
Figure 38. U.S. Antidiabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Antidiabetic Drug Sales Growth Rate (2015-2020) (K MT)
Figure 40. Canada Antidiabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Antidiabetic Drug Market Share by Type in 2019
Figure 42. North America Antidiabetic Drug Market Share by Application in 2019
Figure 43. Europe Antidiabetic Drug Sales Growth Rate 2015-2020 (K MT)
Figure 44. Europe Antidiabetic Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Antidiabetic Drug Sales Market Share by Country in 2019
Figure 46. Europe Antidiabetic Drug Revenue Market Share by Country in 2019
Figure 47. Germany Antidiabetic Drug Sales Growth Rate (2015-2020) (K MT)
Figure 48. Germany Antidiabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Antidiabetic Drug Sales Growth Rate (2015-2020) (K MT)
Figure 50. France Antidiabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Antidiabetic Drug Sales Growth Rate (2015-2020) (K MT)
Figure 52. U.K. Antidiabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Antidiabetic Drug Sales Growth Rate (2015-2020) (K MT)
Figure 54. Italy Antidiabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Antidiabetic Drug Sales Growth Rate (2015-2020) (K MT)
Figure 56. Russia Antidiabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Antidiabetic Drug Market Share by Type in 2019
Figure 58. Europe Antidiabetic Drug Market Share by Application in 2019
Figure 59. Asia Pacific Antidiabetic Drug Sales Growth Rate 2015-2020 (K MT)
Figure 60. Asia Pacific Antidiabetic Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Antidiabetic Drug Sales Market Share by Region in 2019
Figure 62. Asia Pacific Antidiabetic Drug Revenue Market Share by Region in 2019
Figure 63. China Antidiabetic Drug Sales Growth Rate (2015-2020) (K MT)
Figure 64. China Antidiabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Antidiabetic Drug Sales Growth Rate (2015-2020) (K MT)
Figure 66. Japan Antidiabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Antidiabetic Drug Sales Growth Rate (2015-2020) (K MT)
Figure 68. South Korea Antidiabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Antidiabetic Drug Sales Growth Rate (2015-2020) (K MT)
Figure 70. India Antidiabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Antidiabetic Drug Sales Growth Rate (2015-2020) (K MT)
Figure 72. Australia Antidiabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Antidiabetic Drug Sales Growth Rate (2015-2020) (K MT)
Figure 74. Taiwan Antidiabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Antidiabetic Drug Sales Growth Rate (2015-2020) (K MT)
Figure 76. Indonesia Antidiabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Antidiabetic Drug Sales Growth Rate (2015-2020) (K MT)
Figure 78. Thailand Antidiabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Antidiabetic Drug Sales Growth Rate (2015-2020) (K MT)
Figure 80. Malaysia Antidiabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Antidiabetic Drug Sales Growth Rate (2015-2020) (K MT)
Figure 82. Philippines Antidiabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Antidiabetic Drug Sales Growth Rate (2015-2020) (K MT)
Figure 84. Vietnam Antidiabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Antidiabetic Drug Market Share by Type in 2019
Figure 86. Asia Pacific Antidiabetic Drug Market Share by Application in 2019
Figure 87. Latin America Antidiabetic Drug Sales Growth Rate 2015-2020 (K MT)
Figure 88. Latin America Antidiabetic Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Antidiabetic Drug Sales Market Share by Country in 2019
Figure 90. Latin America Antidiabetic Drug Revenue Market Share by Country in 2019
Figure 91. Mexico Antidiabetic Drug Sales Growth Rate (2015-2020) (K MT)
Figure 92. Mexico Antidiabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Antidiabetic Drug Sales Growth Rate (2015-2020) (K MT)
Figure 94. Brazil Antidiabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Antidiabetic Drug Sales Growth Rate (2015-2020) (K MT)
Figure 96. Argentina Antidiabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Antidiabetic Drug Market Share by Type in 2019
Figure 98. Latin America Antidiabetic Drug Market Share by Application in 2019
Figure 99. Middle East and Africa Antidiabetic Drug Sales Growth Rate 2015-2020 (K MT)
Figure 100. Middle East and Africa Antidiabetic Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Antidiabetic Drug Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Antidiabetic Drug Revenue Market Share by Country in 2019
Figure 103. Turkey Antidiabetic Drug Sales Growth Rate (2015-2020) (K MT)
Figure 104. Turkey Antidiabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Antidiabetic Drug Sales Growth Rate (2015-2020) (K MT)
Figure 106. Saudi Arabia Antidiabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Antidiabetic Drug Sales Growth Rate (2015-2020) (K MT)
Figure 108. U.A.E Antidiabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Antidiabetic Drug Market Share by Type in 2019
Figure 110. Middle East and Africa Antidiabetic Drug Market Share by Application in 2019
Figure 111. North America Antidiabetic Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. North America Antidiabetic Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Antidiabetic Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Europe Antidiabetic Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Antidiabetic Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Asia Pacific Antidiabetic Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Antidiabetic Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Latin America Antidiabetic Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Antidiabetic Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Middle East and Africa Antidiabetic Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
経口血糖降下薬（OAD）治療の世界市場（～2026年） Diabetic is the condition where the sugar (glucose) level is high in the blood or the production of the insulin is inadequate. Diabetes main type the very first one is Type 1 and the second is Type 2, both the diabetic are most commonly find in the current scenario, apart from this many other diabet…- αグルコシダーゼ阻害剤の世界市場（～2026年） Alpha-glucosidase is an enzyme that is inhibited by alpha-glucosidase inhibitor drugs. Alpha-glucosidase helps in absorption of carbohydrates by breaking down carbohydrates into tiny sugar molecules such as glucose. The inhibition is reversible, and competitive inhibition. Alpha-glucosidase inhibito…
- GABA受容体アゴニスト薬の世界市場（～2026年） Market Analysis and Insights: Global GABA Receptor Agonist Drug Market The global GABA Receptor Agonist Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global GABA Receptor Agonist Drug Scope and Market Size GABA Recepto…
- 腫瘍壊死因子阻害薬の世界市場（～2026年） Market Analysis and Insights: Global Tumor Necrosis Factor Inhibitors Drug Market The global Tumor Necrosis Factor Inhibitors Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Tumor Necrosis Factor Inhibitors Drug S…
- 小売薬の世界市場（～2026年） A drug is any substance (other than food that provides nutritional support) that, when inhaled, injected, smoked, consumed, absorbed via a patch on the skin, or dissolved under the tongue causes a temporary physiological (and often psychological) change in the body. Increasing industry share of Asia…